| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.62B | 77.23B | 68.56B | 68.97B | 64.64B | 52.37B |
| Gross Profit | 24.82B | 25.28B | 24.52B | 23.01B | 21.46B | 18.03B |
| EBITDA | 8.40B | 9.12B | 9.60B | 9.83B | 10.32B | 8.06B |
| Net Income | 4.81B | 4.78B | 5.49B | 5.89B | 6.62B | 5.01B |
Balance Sheet | ||||||
| Total Assets | 42.83B | 58.21B | 41.52B | 39.09B | 35.60B | 29.48B |
| Cash, Cash Equivalents and Short-Term Investments | 12.35B | 21.09B | 17.53B | 14.47B | 20.63B | 17.41B |
| Total Debt | 1.83B | 12.22B | 1.00B | 1.01B | 1.00B | 1.00B |
| Total Liabilities | 12.88B | 25.55B | 12.65B | 12.31B | 10.68B | 8.91B |
| Stockholders Equity | 29.94B | 30.86B | 28.87B | 25.60B | 23.88B | 19.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 844.00M | 5.08B | 4.86B | 6.51B | 6.19B |
| Operating Cash Flow | 0.00 | 1.36B | 5.76B | 5.16B | 6.80B | 6.37B |
| Investing Cash Flow | 0.00 | -6.04B | 175.00M | -6.37B | -958.00M | -99.00M |
| Financing Cash Flow | 0.00 | 6.16B | -2.87B | -4.95B | -2.62B | -2.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.82T | 29.86 | 27.29% | 0.27% | 3.93% | 29.13% | |
75 Outperform | ¥141.66B | 15.08 | ― | 2.38% | 15.54% | 40.98% | |
69 Neutral | ¥532.63B | 12.37 | 19.18% | 3.59% | 7.21% | 20.34% | |
69 Neutral | ¥107.01B | 14.11 | ― | 7.51% | -14.32% | -17.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥53.09B | 10.86 | ― | 3.66% | 25.14% | 5.40% | |
42 Neutral | ¥55.72B | -12.88 | -6.02% | 0.77% | -3.21% | -104.97% |